[go: up one dir, main page]

PE20091192A1 - Composiciones farmaceuticas que comprenden laxantes y antiespumantes - Google Patents

Composiciones farmaceuticas que comprenden laxantes y antiespumantes

Info

Publication number
PE20091192A1
PE20091192A1 PE2008001615A PE2008001615A PE20091192A1 PE 20091192 A1 PE20091192 A1 PE 20091192A1 PE 2008001615 A PE2008001615 A PE 2008001615A PE 2008001615 A PE2008001615 A PE 2008001615A PE 20091192 A1 PE20091192 A1 PE 20091192A1
Authority
PE
Peru
Prior art keywords
laxants
composition
acidolous
preferibly
peristalysm
Prior art date
Application number
PE2008001615A
Other languages
English (en)
Inventor
Marianne Petersen-Braun
Ulrike Weingartner
Brigitte Havertz
Thomas Schnier
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40044033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091192(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of PE20091192A1 publication Critical patent/PE20091192A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE UN LAXANTE TAL COMO MACROGOLES, LACTULOSA, SORBITOL, MANITOL, XILITOL, ENTRE OTROS; Y UN ANTIESPUMANTE TAL COMO DIMETICONA Y SIMETICONA. DICHA COMPOSICION TAMBIEN PUEDE COMPRENDER UN PRINCIPIO ACTIVO SELECCIONADO DEL GRUPO QUE INCLUYE LOS LAXANTES QUE TIENEN UN EFECTO ANTIABSOCION Y SECRETAGOGO, Y LOS LAXANTES QUE ESTIMULAN EL PERISTALTISMO DEL INTESTINO, PREFERIBLEMENTE DEL GRUPO QUE INCLUYE ANTRAGLICOSIDO, ANTRAQUINONAS, EMODINAS, ACIDO RICINOLEICO, ACEITE DE RICINO, LAXANTES DIFENOLICOS, ACIDOS BILIARES Y COLAGOGOS. SE REFIERE TAMBIEN A UN METODO DE PREPARACION DE UNA COMPOSICION FARMACEUTICA. DICHA COMPOSICION ESTIMULA LA ACTIVIDAD DEL PERISTALTISMO INTESTINAL SIENDO DE UTILIDAD PARA EL TRATAMIENTO DEL ESTRENIMIENTO
PE2008001615A 2007-09-22 2008-09-16 Composiciones farmaceuticas que comprenden laxantes y antiespumantes PE20091192A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07018665 2007-09-22

Publications (1)

Publication Number Publication Date
PE20091192A1 true PE20091192A1 (es) 2009-08-02

Family

ID=40044033

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001615A PE20091192A1 (es) 2007-09-22 2008-09-16 Composiciones farmaceuticas que comprenden laxantes y antiespumantes

Country Status (7)

Country Link
AR (1) AR068530A1 (es)
CL (1) CL2008002758A1 (es)
DE (1) DE112008002398A5 (es)
PE (1) PE20091192A1 (es)
TW (1) TW200930385A (es)
UY (1) UY31343A1 (es)
WO (1) WO2009036906A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0509861A (pt) * 2004-04-13 2007-10-16 Boehringer Ingelheim Int uso de simeticona em pacientes constipados
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
DE102012024434A1 (de) 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
EP2898893A1 (en) * 2014-01-23 2015-07-29 Miklos Varhalmi Improved cholagogue compositions for treating biliary and digestive tract discomfort
US20180318234A1 (en) * 2015-06-22 2018-11-08 Ctc Bio, Inc. Purgative composition for cleansing intestinal tract
IT201700108033A1 (it) 2017-09-27 2019-03-27 Neilos S R L Composizione per il trattamento della costipazione
EP3572068A1 (en) 2018-05-22 2019-11-27 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. New salt of cysteamine for the preparation of highly respirable particles
AU2024287244B1 (en) * 2024-12-28 2025-08-21 Lai, Meng Hong MR A device for relieving constipation and its preparation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
BRPI0509861A (pt) * 2004-04-13 2007-10-16 Boehringer Ingelheim Int uso de simeticona em pacientes constipados

Also Published As

Publication number Publication date
AR068530A1 (es) 2009-11-18
UY31343A1 (es) 2009-03-31
TW200930385A (en) 2009-07-16
CL2008002758A1 (es) 2009-08-14
WO2009036906A1 (de) 2009-03-26
DE112008002398A5 (de) 2010-07-29

Similar Documents

Publication Publication Date Title
PE20091192A1 (es) Composiciones farmaceuticas que comprenden laxantes y antiespumantes
ECSP14012676A (es) Compuestos de carbamato y preparación y uso de los mismos
CL2012003211A1 (es) Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso para preparar los compuestos; composicion farmaceutica que comprende a los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento o prevencion de diabetes tipo 2, obesidad y condiciones relacionadas
CL2013000714A1 (es) Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso de preparacion; composicion farmaceutica que los comprende; metodo de tratamiento; y uso del compuesto para tratar enfermedades tales como diabetes tipo 2, sindrome metabolico, dislipidemia, hipertension y esquizofrenia, entre otras.
EA201790568A1 (ru) Применение двойного агониста рецепторов glp-1/глюкагона пролонгированного действия для лечения неалкогольной жировой болезни печени
CO6771417A2 (es) Antagonistas del receptor de ácido lisofosfatidico y su uso en el tratamiento de fibrosis
GT201200024A (es) Formulación subcutánea de anticuerpo anti-her2
MX2017000080A (es) Conjugados y particulas direccionados y formulaciones de estos.
MX2017005461A (es) Formulacion de buprenorfina inyectable.
CO6410278A2 (es) Disoluciones pediátricas que continen un beta-bloqueante
CL2011000144A1 (es) Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros.
CO6710926A2 (es) Compuestos de n-heteroarilo
WO2011116139A3 (en) Improved pharmaceutical compositions comprising cck- 8 and methods of delivery
CL2009000381A1 (es) Compuestos derivados de tiazol o tiazol-5-carboxamida, inhibidores de la actividad estearoil-coa-desaturasa humana (scd); composicion farmaceutica; y uso para el tratamiento de un trastorno o enfermedad mediada por las enzimas de scd, tal como diabetes, obesidad, enfermedad cardiovascular, lipidos elevados, entre otras.
BR112012015433A2 (pt) composição farmacêutica substancialmente anidra para aplicação cutânea
EA201190161A1 (ru) Способ получения твердых лекарственных форм солифенацина и его фармацевтически приемлемых солей для перорального введения
PE20091949A1 (es) Formulacion farmaceutica solida con liberacion retardada
UY33003A (es) Asociaciones farmacéuticas, composiciones farmacéuticas, medicamento y método para el tratamiento de animales
ES2405531R1 (es) Formulaciones sólidas y su uso en el mantenimiento de la salud gastrointestinal
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
BRPI0512357A (pt) composições compreendendo estrÈncio e vitamina d e usos destas
BR112017025395A2 (pt) formulações farmacêuticas para liberação prolongada de sebacoil éster de dinalbufina
AR077987A1 (es) Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico
MX2020003697A (es) Formulaciones farmaceuticas que comprenden un agonista del receptor opioide como ingredientes activos, metodos de fabricacion y usos terapeuticos de las mismas.
ECSP13013095A (es) Composición farmacéutica que comprende fexofenadina

Legal Events

Date Code Title Description
FD Application declared void or lapsed